EXPD
51
16
MAR
71
3
NKE
28
-12
CA
30
3
PCG
74
2
RCL
68
4
C
82
3
LLY
71
3
HRL
23
-12
THC
47
2
KO
44
-2
EQIX
64
5
CFG
95
2
GOOGL
47
4
SO
46
-5
MTB
73
4
COP
47
3
FDX
74
3
HIG
68
5
EOG
33
-3
EXPD
51
16
MAR
71
3
NKE
28
-12
CA
30
3
PCG
74
2
RCL
68
4
C
82
3
LLY
71
3
HRL
23
-12
THC
47
2
KO
44
-2
EQIX
64
5
CFG
95
2
GOOGL
47
4
SO
46
-5
MTB
73
4
COP
47
3
FDX
74
3
HIG
68
5
EOG
33
-3
Financhill
Back

Netlist, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
49

NLST
Netlist, Inc.

Last Price:
$0.82
Seasonality Move:
65.2%
Sell
23

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$33.50
Seasonality Move:
-0.96%
Sell
49
Netlist, Inc. (NLST) is a Sell

Is Netlist, Inc. a Buy, Sell or Hold?

  • The current Netlist, Inc. [NLST] share price is $0.82. The Score for NLST is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NLST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NLST Stock Price Chart

What is Netlist, Inc.'s stock price today?

  • The Netlist, Inc. share price today is $0.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NLST is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.

NLST Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 63.63 Buy
Chaikin Money Flow: 52036 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.59 - 0.79) Buy
Bollinger Bands (100): (0.62 - 0.84) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.24 Buy
Relative Strength Index (14 RSI): 45.54 Sell
Chaikin Money Flow: 579058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.19 - 34.19) Buy

NLST Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.79 Buy
20-day SMA: 0.73 Buy
50-day SMA: 0.66 Buy
200-day SMA: 0.77 Buy
8-day EMA: 0.79 Buy
20-day EMA: 0.74 Buy
50-day EMA: 0.69 Buy
200-day EMA: 0.46 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.82 Sell
20-day SMA: 34.8 Sell
50-day SMA: 33.74 Sell
200-day SMA: 33.57 Sell
8-day EMA: 17.59 Buy
20-day EMA: 8.61 Buy
50-day EMA: 3.75 Buy
200-day EMA: 0.98 Buy

Netlist, Inc. Earnings Growth & NLST Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.04 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Netlist, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):